The risk of deep venous thrombosis with oral contraceptives containing drospirenone

BMJ. 2011 Apr 21:342:d2519. doi: 10.1136/bmj.d2519.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Androstenes / adverse effects*
  • Contraceptives, Oral, Combined / adverse effects*
  • Female
  • Humans
  • Mineralocorticoid Receptor Antagonists / adverse effects*
  • Venous Thromboembolism / chemically induced*

Substances

  • Androstenes
  • Contraceptives, Oral, Combined
  • Mineralocorticoid Receptor Antagonists
  • drospirenone